CCLD
CareCloud, Inc.
$2.32
-0.01 (-0.43%)
At close · Jul 17
Market Cap
$98.58M
Shares
42,492,949
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$120.5M
+8.7%
FY2025
Net Income
$10.8M
+37.5%
FY2025
Operating Margin
9.41%
+1.2pp
FY2025
Diluted EPS
$0.10
+135.7%
FY2025
Operating Cash Flow
$28.56M
+38.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $128M – $132M | $124.14M | $120.5M | $110.84M | $117.06M | $138.83M | $139.6M | $105.12M | $64.44M | $50.55M | $31.81M | — | — | — | — | |
| — | $7.56M | $6.38M | $3.78M | $4.74M | $4.4M | $4.41M | $9.31M | $871K | $1.03M | $1.08M | $902.19K | $659.18K | $531.68K | $386.11K | |
| — | $5.1M | $4.82M | $6.23M | $9.65M | $9.79M | $8.79M | $6.58M | $1.52M | $1.61M | $1.11M | $1.22M | $467.45K | $253.28K | $248.98K | |
| — | $19.55M | $18.39M | $16.12M | $21.46M | $23.82M | $24.27M | $22.81M | $17.91M | $16.26M | $11.74M | $12.46M | $11.97M | $9.94M | $4.74M | |
| — | — | $12.45M | $12.1M | $12.4M | $9.77M | $10.23M | $8.54M | $2.06M | $2.1M | $3.65M | $4.58M | $4.18M | $2.53M | $715.1K | |
| — | $15.66M | $14.96M | $14.14M | $14.4M | $11.73M | $12.2M | $9.91M | $3.01M | $2.85M | $4.3M | $5.11M | $4.6M | $2.79M | $948.53K | |
| — | $255K | — | $606K | $645K | — | — | — | $49K | — | $275.63K | — | — | — | — | |
| — | $113.81M | $109.16M | $101.72M | $164.17M | $132.22M | $136.07M | $113.39M | $64.37M | $53.09M | $36.33M | $32.39M | $27.54M | $22.34M | $10.6M | |
| — | $10.32M | $11.34M | $9.12M | -$47.12M | $6.61M | $3.53M | -$8.27M | $67K | -$2.54M | -$4.52M | -$7.9M | -$4.46M | -$4.04M | -$127.52K | |
| — | — | 9.41% | 8.23% | -40.25% | 4.76% | 2.53% | -7.87% | 0.1% | -5.02% | -14.22% | — | — | — | — | |
| — | $25.98M | $26.3M | $23.26M | -$32.71M | $18.34M | $15.72M | $1.63M | $3.07M | $314.01K | -$222.22K | -$2.79M | $140.35K | -$1.25M | $821.02K | |
| — | -$229K | -$265K | -$298K | -$883K | -$637K | -$96K | $7000 | -$625K | $494.33K | $332.08K | -$53.28K | $170.28K | -$134.72K | $230.15K | |
| — | $9.98M | $11M | $8.01M | -$49.04M | $5.61M | $2.99M | -$8.71M | -$679K | -$2.3M | -$5.5M | -$8.6M | -$4.55M | -$4.33M | -$33.51K | |
| — | $210K | $199K | $160K | -$364K | $177K | $157K | $103K | $193K | -$157.39K | $67.81K | $196.8K | $137.79K | $176.53K | $144.49K | |
| — | $9.77M | $10.8M | $7.85M | -$48.67M | $5.43M | $2.84M | -$8.81M | -$872K | -$2.14M | -$5.57M | -$8.8M | -$4.69M | -$4.51M | -$178K | |
| — | — | 8.96% | 7.08% | -41.58% | 3.91% | 2.03% | -8.38% | -1.35% | -4.23% | -17.49% | — | — | — | — | |
| — | $4.31M | $3.89M | -$4.46M | -$64.35M | -$10.09M | -$11.22M | -$22.69M | -$7.26M | -$6.96M | -$7.6M | -$9.55M | -$4.89M | -$4.51M | -$178K | |
| — | $9.88M | $10.82M | $7.72M | -$49.51M | $4.15M | $2.09M | -$8.97M | -$294K | -$2.84M | -$5.91M | -$8.77M | -$4.88M | -$4.53M | -$287.58K | |
| USD/shares | — | — | $0.10 | -$0.28 | -$4.11 | -$0.67 | -$0.77 | — | — | — | — | — | — | -$0.64 | -$0.03 |
| USD/shares | $0.20 – $0.23 | — | $0.10 | -$0.28 | -$4.11 | -$0.67 | — | — | — | — | — | — | — | -$0.64 | -$0.03 |
| shares | — | — | 37.79M | 16.15M | 15.67M | 15.11M | 14.54M | 12.68M | 12.09M | 11.72M | 11.01M | 10.04M | 9.73M | 7.08M | 5.1M |
| shares | — | — | 37.95M | 16.15M | 15.67M | 15.11M | 14.54M | 12.68M | 12.09M | 11.72M | 11.01M | 10.04M | 9.73M | 7.08M | 5.1M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2014–FY2016: $668.18K in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Health Information Services median 1.36×
EV/EBIT
—
Health Information Services median 25.83×
P/E (TTM)
17.85×
Health Information Services median 33.24×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Healthcare IT | $106,566,000 | $96,405,000 | $103,683,000 | $125,276,000 | $127,080,000 | — |
| Medical Practice Management | $13,933,000 | $14,432,000 | $13,376,000 | $13,550,000 | $12,519,000 | — |
| Healthcare IT | — | — | — | — | — | $93,324,000 |
| Medical Practice Management | — | — | — | — | — | $11,798,000 |
By Product & Service (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Chronic Care Management | $2,800,000 | $3,000,000 | $1,500,000 | $208,000 |
| Remote Patient Monitoring | $794,000 | $779,000 | $400,000 | $6,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Healthcare IT | $17,600,000 | $12,976,000 | -$39,129,000 | $15,439,000 | $11,682,000 | — |
| Medical Practice Management | -$313,000 | $1,264,000 | $632,000 | $631,000 | $130,000 | — |
| UnallocatedCorporateExpenses | — | — | -$8,618,000 | -$9,460,000 | -$8,283,000 | — |
| Healthcare IT | — | — | — | — | — | -$2,317,000 |
| Medical Practice Management | — | — | — | — | — | $301,000 |
| Unallocated Corporate Expenses | — | — | — | — | — | -$6,255,000 |
Operating Margin by Segment (%)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Healthcare IT | 16.5% | 13.5% | -37.7% | 12.3% | 9.2% | — |
| Medical Practice Management | -2.2% | 8.8% | 4.7% | 4.7% | 1% | — |
| Healthcare IT | — | — | — | — | — | -2.5% |
| Medical Practice Management | — | — | — | — | — | 2.6% |